Zoetis
ZTS
$0.51 (0.42%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 1 day ago • ZTS
These 2 Healthcare Stocks Just Declared Dividend Raises
Zacks Investment Research • 1 day ago • ZTS
4 Stocks That Declared Dividend Hikes Amid Ongoing Economic Uncertainty
Business Wire • 3 days ago • ZTS
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
Business Wire • 3 days ago • ZTS
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
Seeking Alpha • 3 days ago • ZTS
Gabelli Pet Parents' Fund Q3 2025 Contributors And Detractors
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.